Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Earnings vs. Expectations
Compare| Mar 2012* | Jun 2012* | Sep 2012* | Dec 2012* | Mar 2013* | |
| * Quarter Ending | |||||
|---|---|---|---|---|---|
| Estimated EPS($) | -0.20 | 0.23 | 0.90 | 1.10 | 0.81 |
| Reported EPS($) | 0.11 | 0.70 | 1.72 | 4.08 | NA |
| GAAP($) | 0.11 | 0.70 | 1.72 | 4.08 | NA |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
| Average Estimate ($) | 0.81 | 0.95 | 4.42 | 5.80 |
| Number of Analysts | 15 | 16 | 18 | 17 |
| Low Estimate ($) | 0.56 | 0.69 | 2.91 | 3.59 |
| High Estimate ($) | 1.23 | 1.36 | 8.57 | 10.72 |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
|---|---|---|---|---|
| Current Estimate ($) | 0.81 | 0.95 | 4.42 | 5.80 |
| 30 Days Ago ($) | 0.82 | 0.96 | 4.38 | 5.74 |
| 90 Days Ago ($) | 1.05 | 1.17 | 5.19 | 6.20 |
| Dec 2013* | Dec 2014* | Next 3 Years (per year) | Forward P/E | PEG | ||
| * Year Ending | ||||||
|---|---|---|---|---|---|---|
| REGN | -247.99% | 19.94% | 22.34% | 46.88 | 1.32 | |
